LPCAT2 anticorps (C-Term)
Aperçu rapide pour LPCAT2 anticorps (C-Term) (ABIN928136)
Antigène
Voir toutes LPCAT2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Souris
-
Purification
- Purified
-
Immunogène
- Lpcat2 antibody was raised in rabbit using the C terminal of Lpcat2 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
Lpcat2 Blocking Peptide, (ABIN940385), is also available for use as a blocking control in assays to test for specificity of this Lpcat2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LPCAT2 (Lysophosphatidylcholine Acyltransferase 2 (LPCAT2))
-
Autre désignation
- Lpcat2
-
Sujet
- Lpcat2 possesses both acyltransferase and acetyltransferase activities. Activity is calcium-dependent. It is involved in platelet-activating factor (PAF) biosynthesis by catalyzing the conversion of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF). It also converts lyso-PAF to 1-alkyl-phosphatidylcholine (PC), a major component of cell membranes and a PAF precursor. Under resting conditions, acyltransferase activity is preferred. Upon acute inflammatory stimulus, acetyltransferase activity is enhanced and PAF synthesis increases. Synonyms: Polyclonal Lpcat2 antibody, Anti-Lpcat2 antibody, lysophosphatidylcholine acyltransferase 2 antibody, A330042H22 antibody, Aytl1 antibody, LPCAT2 antibody, lpafat1 antibody.
Antigène
-